Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
TELA BIO INC
TELA | US
0.57
USD-0.03
-4.73%
TELA | US
Loading StockChartView...
About TELA BIO INC
Sector
Healthcare
Industry
Medical Devices
Earnings date
30/06/2024
As of date
10/04/2026
Close
0.57
Open
0.60
High
0.62
Low
0.56
TELA Bio Inc. a commercial-stage medical technology company focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery as well as OviTex for Laparoscopic and Robotic Procedures a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force principally in the United States. TELA Bio Inc. was incorporated in 2012 and is headquartered in Malvern Pennsylvania.
View LessTELA | US
Risk
124.7
Sharpe
-0.55
Luna's Score
31/100
Recommendation
Sell
Luna says (TELA | US)
What's Working
Strong Revenue Growth (> 10%)
What's not Working
Negative Momentum (Declining Price)
Price Below SMA10D
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
High Debt to Equity (> 0.75)
High Debt to Asset (> 0.45)
Rich in Valuation (Price to Book > 8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
142.9%1 month
124.7%3 months
89.4%6 months
78.3%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
21.79
Debt to equity
14.42
Debt to assets
0.69
Ent. to EBITDA
-5.01
Ent. to rev.
1.20
PEG
-
Other Fundamentals
EBITDA
-45.57M
MarketCap
14.02M
MarketCap(USD)
14.02M
Div. yield
-
Op. margin
-71.90
Erngs. growth
-
Rev. growth
11.00
Ret. on equity
-196.42
Short ratio
9.63
Short perc.
11.31
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
0.29
Range1M
0.40
Range3M
0.68
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.36
Price X volume
40.70K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -5.01 | 46.09 | Cheaper |
| Ent. to Revenue | 1.20 | 14.34 | Cheaper |
| PE Ratio | - | 30.41 | - |
| Price to Book | 21.79 | 6.21 | Expensive |
| Dividend Yield | - | 1.78 | - |
| Std. Deviation (3M) | 89.40 | 64.12 | Riskier |
| Debt to Equity | 14.42 | -145.53 | Expensive |
| Debt to Assets | 0.69 | 0.35 | Expensive |
| Market Cap | 14.02M | 9.70B | Emerging |
